Skip to main content
Top
Published in: World Journal of Surgery 3/2014

01-03-2014

Muscle Function Is Impaired in Patients With “Asymptomatic” Primary Hyperparathyroidism

Authors: Lars Rolighed, Anne Kristine Amstrup, Niels Frederik Breum Jakobsen, Tanja Sikjaer, Leif Mosekilde, Peer Christiansen, Lars Rejnmark

Published in: World Journal of Surgery | Issue 3/2014

Login to get access

Abstract

Background

Patients with “asymptomatic” primary hyperparathyroidism (PHPT) often describe improvement after surgery.

Methods

We evaluated muscle and balance function, quality of life (QoL), and well-being in 58 PHPT patients and 58 population-based matched controls in a cross-sectional study. We tested whether patients considered “asymptomatic” according to international guidelines have functional impairment.

Results

Mean age of the patients and controls was 59 years, and 47 (81 %) were women. Patients had higher levels of plasma PTH and ionized calcium. Creatinine and 25-hydroxyvitamin D levels did not differ between groups. Altogether, 16 (28 %) patients were “asymptomatic.” Compared with controls, PHPT was associated with significantly lower QoL in all eight domains of the short form-36 questionnaire, lower well-being (WHO Five Well-Being Index; p < 0.001), and impaired postural stability during normal standing with eyes open (p < 0.05) or closed (p < 0.001). Maximum isometric muscle strength was reduced in both upper (p < 0.01) and lower (p < 0.001) extremities. Physical performance was decreased during 10 repeated chair stands (p < 0.001) and time to walk 3 m forward and back (p < 0.05). Restricting analyses to “asymptomatic” patients showed significantly lower muscle strength at knee extension and flexion and impaired postural stability than in matched controls.

Conclusions

PHPT is associated with deleterious effects on muscles and QoL. Impairments also apply to patients with mild disease, normally considered “asymptomatic.” This may explain why “asymptomatic” patients report improvements following surgery. The impaired muscle function may contribute to increased fracture risk independent of bone mineral density.
Literature
1.
go back to reference Bollerslev J, Marcocci C, Sosa M et al (2011) Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. Eur J Endocrinol 165:851–864PubMedCrossRef Bollerslev J, Marcocci C, Sosa M et al (2011) Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. Eur J Endocrinol 165:851–864PubMedCrossRef
3.
4.
go back to reference Bilezikian JP, Potts JT Jr, Fuleihan G et al (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 87:5353–5361PubMedCrossRef Bilezikian JP, Potts JT Jr, Fuleihan G et al (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 87:5353–5361PubMedCrossRef
5.
go back to reference Silverberg SJ, Lewiecki EM, Mosekilde L et al (2009) Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94:351–365PubMedCrossRef Silverberg SJ, Lewiecki EM, Mosekilde L et al (2009) Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94:351–365PubMedCrossRef
6.
go back to reference Morris GS, Grubbs EG, Hearon CM et al (2010) Parathyroidectomy improves functional capacity in “asymptomatic” older patients with primary hyperparathyroidism: a randomized control trial. Ann Surg 251:832–837PubMedCrossRef Morris GS, Grubbs EG, Hearon CM et al (2010) Parathyroidectomy improves functional capacity in “asymptomatic” older patients with primary hyperparathyroidism: a randomized control trial. Ann Surg 251:832–837PubMedCrossRef
7.
go back to reference Perrier ND, Balachandran D, Wefel JS et al (2009) Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with “asymptomatic” primary hyperparathyroidism. Surgery 146:1116–1122PubMedCrossRef Perrier ND, Balachandran D, Wefel JS et al (2009) Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with “asymptomatic” primary hyperparathyroidism. Surgery 146:1116–1122PubMedCrossRef
9.
go back to reference Jansson S, Grimby G, Hagne I et al (1991) Muscle structure and function before and after surgery for primary hyperparathyroidism. Eur J Surg 157:13–16PubMed Jansson S, Grimby G, Hagne I et al (1991) Muscle structure and function before and after surgery for primary hyperparathyroidism. Eur J Surg 157:13–16PubMed
10.
go back to reference Hedman I, Grimby G, Tisell LE (1984) Improvement of muscle strength after treatment for hyperparathyroidism. Acta Chir Scand 150:521–524PubMed Hedman I, Grimby G, Tisell LE (1984) Improvement of muscle strength after treatment for hyperparathyroidism. Acta Chir Scand 150:521–524PubMed
11.
go back to reference Quiros RM, Alef MJ, Wilhelm SM et al (2003) Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomy. Surgery 134:675–681 discussion 681–683PubMedCrossRef Quiros RM, Alef MJ, Wilhelm SM et al (2003) Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomy. Surgery 134:675–681 discussion 681–683PubMedCrossRef
12.
go back to reference Weber T, Eberle J, Messelhauser U et al (2012) Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study. Arch Surg 15:1–7 Weber T, Eberle J, Messelhauser U et al (2012) Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study. Arch Surg 15:1–7
13.
go back to reference Amstrup AK, Rejnmark L, Vestergaard P et al (2011) Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls: a cross-sectional study. Clin Endocrinol (Oxf) 74:130–136CrossRef Amstrup AK, Rejnmark L, Vestergaard P et al (2011) Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls: a cross-sectional study. Clin Endocrinol (Oxf) 74:130–136CrossRef
14.
go back to reference Amstrup AK, Rejnmark L, Mosekilde L (2011) Patients with surgically cured primary hyperparathyroidism have a reduced quality of life compared with population-based healthy sex-, age-, and season-matched controls. Eur J Endocrinol 165:753–760PubMedCrossRef Amstrup AK, Rejnmark L, Mosekilde L (2011) Patients with surgically cured primary hyperparathyroidism have a reduced quality of life compared with population-based healthy sex-, age-, and season-matched controls. Eur J Endocrinol 165:753–760PubMedCrossRef
15.
go back to reference Jakobsen NF, Rolighed L, Nissen PH et al (2013) Muscle function and quality of life is not impaired in familial hypocalciuric hypercalcemia (FHH): a cross-sectional study on physiological effects of inactivating variants in the calcium sensing receptor gene (CaSR). Eur J Endocrinol 169:349–357PubMedCrossRef Jakobsen NF, Rolighed L, Nissen PH et al (2013) Muscle function and quality of life is not impaired in familial hypocalciuric hypercalcemia (FHH): a cross-sectional study on physiological effects of inactivating variants in the calcium sensing receptor gene (CaSR). Eur J Endocrinol 169:349–357PubMedCrossRef
16.
go back to reference Maunsell Z, Wright DJ, Rainbow SJ (2005) Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 51:1683–1690PubMedCrossRef Maunsell Z, Wright DJ, Rainbow SJ (2005) Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 51:1683–1690PubMedCrossRef
17.
go back to reference Curb JD, Ceria-Ulep CD, Rodriguez BL et al (2006) Performance-based measures of physical function for high-function populations. J Am Geriatr Soc 54:737–742PubMedCrossRef Curb JD, Ceria-Ulep CD, Rodriguez BL et al (2006) Performance-based measures of physical function for high-function populations. J Am Geriatr Soc 54:737–742PubMedCrossRef
18.
go back to reference Ambrogini E, Cetani F, Cianferotti L et al (2007) Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 92:3114–3121PubMedCrossRef Ambrogini E, Cetani F, Cianferotti L et al (2007) Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 92:3114–3121PubMedCrossRef
19.
go back to reference Bollerslev J, Jansson S, Mollerup CL et al (2007) Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92:1687–1692PubMedCrossRef Bollerslev J, Jansson S, Mollerup CL et al (2007) Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92:1687–1692PubMedCrossRef
20.
go back to reference Rao DS, Phillips ER, Divine GW et al (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89:5415–5422PubMedCrossRef Rao DS, Phillips ER, Divine GW et al (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89:5415–5422PubMedCrossRef
21.
go back to reference De Wit M, Pouwer F, Gemke RJ et al (2007) Validation of the WHO-5 Well-Being Index in adolescents with type 1 diabetes. Diabetes Care 30:2003–2006PubMedCrossRef De Wit M, Pouwer F, Gemke RJ et al (2007) Validation of the WHO-5 Well-Being Index in adolescents with type 1 diabetes. Diabetes Care 30:2003–2006PubMedCrossRef
22.
go back to reference Arthur ST, Cooley ID (2012) The effect of physiological stimuli on sarcopenia: impact of Notch and Wnt signaling on impaired aged skeletal muscle repair. Int J Biol Sci 8:731–760PubMedCentralPubMedCrossRef Arthur ST, Cooley ID (2012) The effect of physiological stimuli on sarcopenia: impact of Notch and Wnt signaling on impaired aged skeletal muscle repair. Int J Biol Sci 8:731–760PubMedCentralPubMedCrossRef
23.
go back to reference Mosekilde L (2008) Primary hyperparathyroidism and the skeleton. Clin Endocrinol (Oxf) 69:1–19CrossRef Mosekilde L (2008) Primary hyperparathyroidism and the skeleton. Clin Endocrinol (Oxf) 69:1–19CrossRef
25.
go back to reference Bolland MJ, Grey AB, Orr-Walker BJ et al (2008) Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism. N Z Med J 121:18–29PubMed Bolland MJ, Grey AB, Orr-Walker BJ et al (2008) Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism. N Z Med J 121:18–29PubMed
26.
go back to reference Khan A, Grey A, Shoback D (2009) Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94:373–381PubMedCrossRef Khan A, Grey A, Shoback D (2009) Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94:373–381PubMedCrossRef
27.
go back to reference Bilezikian JP, Khan AA, Potts JT Jr (2009) Third international workshop on the management of asymptomatic primary hyperthyroidism: guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 94:335–339PubMedCrossRef Bilezikian JP, Khan AA, Potts JT Jr (2009) Third international workshop on the management of asymptomatic primary hyperthyroidism: guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 94:335–339PubMedCrossRef
28.
go back to reference Cetani F, Pardi E, Borsari S et al (2011) Molecular pathogenesis of primary hyperparathyroidism. J Endocrinol Invest 34(Suppl):35–39PubMed Cetani F, Pardi E, Borsari S et al (2011) Molecular pathogenesis of primary hyperparathyroidism. J Endocrinol Invest 34(Suppl):35–39PubMed
29.
go back to reference Reppe S, Stilgren L, Abrahamsen B et al (2007) Abnormal muscle and hematopoietic gene expression may be important for clinical morbidity in primary hyperparathyroidism. Am J Physiol Endocrinol Metab 292:E1465–E1473PubMedCrossRef Reppe S, Stilgren L, Abrahamsen B et al (2007) Abnormal muscle and hematopoietic gene expression may be important for clinical morbidity in primary hyperparathyroidism. Am J Physiol Endocrinol Metab 292:E1465–E1473PubMedCrossRef
30.
go back to reference Smock SL, Vogt GA, Castleberry TA et al (2001) Molecular cloning and functional characterization of the canine parathyroid hormone/parathyroid hormone related peptide receptor (PTH1). Mol Biol Rep 28:235–243PubMedCrossRef Smock SL, Vogt GA, Castleberry TA et al (2001) Molecular cloning and functional characterization of the canine parathyroid hormone/parathyroid hormone related peptide receptor (PTH1). Mol Biol Rep 28:235–243PubMedCrossRef
31.
go back to reference Ward BK, Magno AL, Walsh JP et al (2012) The role of the calcium-sensing receptor in human disease. Clin Biochem 45:943–953PubMedCrossRef Ward BK, Magno AL, Walsh JP et al (2012) The role of the calcium-sensing receptor in human disease. Clin Biochem 45:943–953PubMedCrossRef
32.
go back to reference Vestergaard P, Mollerup CL, Frokjaer VG et al (2000) Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ 321:598–602PubMedCrossRef Vestergaard P, Mollerup CL, Frokjaer VG et al (2000) Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ 321:598–602PubMedCrossRef
33.
go back to reference Yoshimura N, Oka H, Muraki S et al (2011) Reference values for hand grip strength, muscle mass, walking time, and one-leg standing time as indices for locomotive syndrome and associated disability: the second survey of the ROAD study. J Orthop Sci 16:768–777PubMedCrossRef Yoshimura N, Oka H, Muraki S et al (2011) Reference values for hand grip strength, muscle mass, walking time, and one-leg standing time as indices for locomotive syndrome and associated disability: the second survey of the ROAD study. J Orthop Sci 16:768–777PubMedCrossRef
34.
go back to reference Harbo T, Brincks J, Andersen H (2012) Maximal isokinetic and isometric muscle strength of major muscle groups related to age, body mass, height, and sex in 178 healthy subjects. Eur J Appl Physiol 112:267–275PubMedCrossRef Harbo T, Brincks J, Andersen H (2012) Maximal isokinetic and isometric muscle strength of major muscle groups related to age, body mass, height, and sex in 178 healthy subjects. Eur J Appl Physiol 112:267–275PubMedCrossRef
35.
go back to reference Janssen I, Heymsfield SB, Ross R (2002) Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50:889–896PubMedCrossRef Janssen I, Heymsfield SB, Ross R (2002) Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50:889–896PubMedCrossRef
36.
go back to reference Rolighed L, Vestergaard P, Heickendorff L et al (2013) BMD improvements after operation for primary hyperparathyroidism. Langenbecks Arch Surg 398:113–120PubMedCrossRef Rolighed L, Vestergaard P, Heickendorff L et al (2013) BMD improvements after operation for primary hyperparathyroidism. Langenbecks Arch Surg 398:113–120PubMedCrossRef
Metadata
Title
Muscle Function Is Impaired in Patients With “Asymptomatic” Primary Hyperparathyroidism
Authors
Lars Rolighed
Anne Kristine Amstrup
Niels Frederik Breum Jakobsen
Tanja Sikjaer
Leif Mosekilde
Peer Christiansen
Lars Rejnmark
Publication date
01-03-2014
Publisher
Springer US
Published in
World Journal of Surgery / Issue 3/2014
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-013-2273-5

Other articles of this Issue 3/2014

World Journal of Surgery 3/2014 Go to the issue